{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": -2.6845691, "regularMarketPrice": 0.29, "marketState": "REGULAR", "currency": "EUR", "exchange": "FRA", "shortName": "ASCLETIS PHARMA  DL-,0001", "longName": "Ascletis Pharma Inc.", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "messageBoardId": "finmb_574413177", "regularMarketChange": -0.008000016, "regularMarketTime": 1683875701, "regularMarketDayHigh": 0.29, "regularMarketDayRange": "0.29 - 0.29", "regularMarketDayLow": 0.29, "regularMarketVolume": 3000, "regularMarketPreviousClose": 0.298, "bid": 0.278, "ask": 0.308, "bidSize": 0, "askSize": 0, "fullExchangeName": "Frankfurt", "financialCurrency": "CNY", "regularMarketOpen": 0.29, "averageDailyVolume3Month": 50, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.035999984, "fiftyTwoWeekLowChangePercent": 0.14173222, "fiftyTwoWeekRange": "0.254 - 0.615", "fiftyTwoWeekHighChange": -0.32500002, "fiftyTwoWeekHighChangePercent": -0.5284553, "fiftyTwoWeekLow": 0.254, "fiftyTwoWeekHigh": 0.615, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.04, "sharesOutstanding": 1087129984, "bookValue": 2.336, "fiftyDayAverage": 0.31392, "fiftyDayAverageChange": -0.02392, "fiftyDayAverageChangePercent": -0.07619776, "twoHundredDayAverage": 0.38452, "twoHundredDayAverageChange": -0.09452, "twoHundredDayAverageChangePercent": -0.24581297, "marketCap": 332087680, "priceToBook": 0.12414383, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1533794400000, "priceHint": 4, "symbol": "2VJ.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Building D", "address2": "12th Floor 198 Qidi Road, HIPARK Xiaoshan District", "city": "Hangzhou", "country": "China", "phone": "86 571 8538 9730", "website": "https://www.ascletis.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating chronic hepatitis B (CHB); ASC42 for chronic hepatitis B functional cure; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC, ASC44F FDC, and ASC45F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma, drug resistant breast cancer, and KRAS mutant non-small cell lung cancer; ASC61 and ASC63 for advanced solid tumors; ASC60 to treat solid tumors; and ASC40 for the treatment of acne. Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China.", "fullTimeEmployees": 278, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jinzi Jason  Wu Ph.D.", "age": 58, "title": "Founder, Chairman & CEO", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 3266662, "fmt": "3.27M", "longFmt": "3,266,662"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Hejingdao  Wu", "age": 47, "title": "Sr. VP of Operations & Exec. Director", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 385768, "fmt": "385.77k", "longFmt": "385,768"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Handan  He Ph.D.", "age": 60, "title": "Chief Scientific Officer", "yearBorn": 1962, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Yuemei  Yan", "age": 52, "title": "Sr. VP of Clinical Devel. Operations", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Kristjan Sigurdur Gudmundsson", "age": 54, "title": "Sr. Consultant & Head of Discovery", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. George Zhengzhi Hill", "age": 71, "title": "Sr. Consultant & Chief Medical Advisor", "yearBorn": 1951, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John P. Gargiulo M.B.A.", "title": "Chief Bus. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ming Fai  Chung CPA", "age": 43, "title": "Company Sec.", "yearBorn": 1979, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}